Should be update the Melanoma guidelines now?

Sitting in an exciting Melanoma session at ASCO- the discussion is Ipi versus PD1 first-line.

'Ipi is no longer to be considered 1st line treatment'

' it has been superseded by PD1'

'we should update the Melanoma guidelines after this ASCO'


Things are moving fast and the PD1 data and the Ipi/ Nivo combo are great news for us!